当前位置: 首页 >> 检索结果
共有 38500 条符合本次的查询结果, 用时 9.4237839 秒

1341. Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma.

作者: John Oppenheimer.;Nicola A Hanania.;Rekha Chaudhuri.;Hironori Sagara.;Zelie Bailes.;Andrew Fowler.;Guy Peachey.;Emilio Pizzichini.;David Slade.
来源: Chest. 2023年164卷5期1087-1096页
Studies examining agreement between home and clinic spirometry in patients with asthma are limited, with conflicting results. Understanding the strengths and limitations of telehealth and home spirometry is particularly important considering the SARS-CoV-2 pandemic.

1342. Nocturnal BP Profile Predicts CPAP Effect on BP in Patients With OSA and Resistant Hypertension.

作者: Martino F Pengo.;Grace Oscullo.;Jose Daniel Gomez-Olivas.;Grzegorz Bilo.;Gianfranco Parati.;Miguel Angel Martinez-Garcia.
来源: Chest. 2023年164卷5期1302-1304页

1343. Screening for Exposure to Beryllium Among US Veterans With a Diagnosis of Sarcoidosis, 2002-2020.

作者: Mohamed I Seedahmed.;Mohamed T Albirair.;Mary A Whooley.;Laura L Koth.;Paul D Blanc.;Mehrdad Arjomandi.
来源: Chest. 2023年164卷5期1253-1256页

1344. Preserved Ratio Impaired Spirometry and Risks of Macrovascular, Microvascular Complications and Mortality Among Individuals With Type 2 Diabetes.

作者: Guochen Li.;Matthew D Jankowich.;Luying Wu.;Yanqiang Lu.;Liping Shao.;Xujia Lu.;Yulong Fan.;Chen-Wei Pan.;Ying Wu.;Chaofu Ke.
来源: Chest. 2023年164卷5期1268-1280页
The prospective associations of preserved ratio impaired spirometry (PRISm) with new-onset macrovascular and microvascular complications and mortality among individuals with type 2 diabetes (T2D) and whether PRISm enhances the prediction ability of an established office-based risk score remain to be elucidated.

1345. Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.

作者: Charles Fauvel.;Yongqi Liu.;Priscilla Correa-Jaque.;Manreet K Kanwar.;Carmine Dario Vizza.;Shili Lin.;Raymond L Benza.
来源: Chest. 2023年164卷6期1518-1530页
Based on results of the Ambrisentan and Tadalafil in Patients with Pulmonary Arterial Hypertension (AMBITION) trial, upfront combination therapy is recommended for treatment-naive patients with low-risk pulmonary arterial hypertension (PAH). However, conflicting data exist whether adopting this treatment strategy in this risk group is beneficial or well tolerated.

1346. Emotional Distress, Anxiety, and General Health Status in Patients With Newly Identified Small Pulmonary Nodules: Results From the Watch the Spot Trial.

作者: Michael K Gould.;Beth Creekmur.;Lihong Qi.;Sara E Golden.;Celia P Kaplan.;Eric Walter.;Richard A Mularski.;Laszlo T Vaszar.;Kathleen Fennig.;Julie Steiner.;Evan de Bie.;Visanee V Musigdilok.;Danielle A Altman.;Debra S Dyer.;Karen Kelly.;Diana L Miglioretti.;Renda Soylemez Wiener.;Christopher G Slatore.;Rebecca Smith-Bindman.
来源: Chest. 2023年164卷6期1560-1571页
Anxiety and emotional distress have not been studied in large, diverse samples of patients with pulmonary nodules.

1347. Incident Coronary Calcium Score in Patients With OSA With and Without Excessive Sleepiness: Brazilian Longitudinal Study of Adult Health.

作者: Érique José Farias Peixoto de Miranda.;Diego R Mazzotti.;Ronaldo B Santos.;Silvana P Souza.;Barbara K Parise.;Soraya Giatti.;Aline N Aielo.;Lorenna F Cunha.;Wagner A Silva.;Luiz A Bortolotto.;Geraldo Lorenzi-Filho.;Paulo A Lotufo.;Isabela M Bensenor.;Márcio S Bittencourt.;Luciano F Drager.
来源: Chest. 2024年165卷1期202-212页
Uncertainty exists about the impact of OSA and its phenotypes on cardiovascular disease.

1348. Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19: A Randomized, Placebo-Controlled Dosing Clinical Trial.

作者: Amy L Lightner.;Vikram Sengupta.;Sascha Qian.;John T Ransom.;Sam Suzuki.;David J Park.;Timothy I Melson.;Brian P Williams.;James J Walsh.;Mustafa Awili.
来源: Chest. 2023年164卷6期1444-1453页
Bone marrow mesenchymal stem cell (BM-MSC)-derived extracellular vesicles (ExoFlo) convey the immunomodulatory and regenerative properties of intact BM-MSCs. This study aimed to determine the safety and efficacy of ExoFlo as treatment for moderate to severe ARDS in patients with severe COVID-19.

1349. Restrictive Visitation Policies and Related Post-Traumatic Stress Among Families of Critically Ill Patients With COVID-19.

作者: Katherine R White.;Jane J Lee.;Kalli A Sarigiannis.;Jonathan J Tringali.;James Vu.;Ashley Eaton England.;Stephanie Lietzau.;Charles Hebert.;David Banayan.;Santosh Basapur.;Crystal M Glover.;Raj C Shah.;James Gerhart.;Jared A Greenberg.
来源: Chest. 2023年164卷6期1462-1465页

1350. Liberation From Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure: A Scoping Review.

作者: Ricardo Teijeiro-Paradis.;Tsega Cherkos Dawit.;Laveena Munshi.;Niall D Ferguson.;Eddy Fan.
来源: Chest. 2023年164卷5期1184-1203页
Safe and timely liberation from venovenous extracorporeal membrane oxygenation (ECMO) would be expected to reduce the duration of ECMO, the risk of complications, and costs. However, how to liberate patients from venovenous ECMO effectively remains understudied.

1351. Predictors of Thrombus Resolution Among Patients Who Undergo Anticoagulation for a Right Heart Thrombus.

作者: Nathan W Watson.;Andrew B Dicks.;Brett J Carroll.;Alec Schmaier.;Eric A Secemsky.
来源: Chest. 2023年164卷5期1298-1301页

1352. Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis of Patients With Melanoma: A Prospective Multicenter Study of 443 Patients.

作者: Jose Daniel Gómez-Olivas.;Francisco Campos-Rodriguez.;Eduardo Nagore.;Antonio Martorell.;Francisco García-Rio.;Carolina Cubillos.;Luis Hernandez.;Jose Bañuls.;Eva Arias.;Pablo Ortiz.;Valentin Cabriada.;Juan Gardeazabal.;Josep Maria Montserrat.;Cristina Carrera.;Juan Fernando Masa.;Javier Gomez de Terreros.;Jorge Abad.;Adam Boada.;Olga Mediano.;Marta Castillo-Garcia.;Eusebi Chiner.;Pedro Landete.;Mercedes Mayos.;Ana Fortuna.;Ferrán Barbé.;Manuel Sanchez-de-la-Torre.;Irene Cano-Pumarega.;Amalia Perez-Gil.;Teresa Gomez-Garcia.;Daniela Cullen.;Maria Somoza.;Manuel Formigon.;Felipe Aizpuru.;Grace Oscullo.;Alberto Garcia-Ortega.;Isaac Almendros.;Ramón Farré.;David Gozal.;Miguel Angel Martinez-Garcia.
来源: Chest. 2023年164卷6期1551-1559页
OSA has been associated with increased incidence and aggressiveness of melanoma. However, the long-term impact of OSA and CPAP treatment on the prognosis of melanoma remains unexplored.

1353. Intranasal Corticosteroids for Childhood OSA Syndrome: The Jury Is Still Out.

作者: Emmanouil I Alexopoulos.;Athanasios G Kaditis.
来源: Chest. 2023年163卷6期e292页

1354. Response.

作者: Daniel Okin.;George A Alba.;Lisa M Bebell.;Peggy S Lai.
来源: Chest. 2023年163卷6期e291页

1355. Highlighting Prospective Data on Prolonged Prone Positioning.

作者: David B Page.;Derek W Russell.
来源: Chest. 2023年163卷6期e290-e291页

1356. Response.

作者: Amany F Elbehairy.;Nesma M Geneidy.;Mona S Elhoshy.;Asmaa Abd-Elhameed.;Alexander Horsley.;Denis E O'Donnell.;Nashwa H Abd-Elwahab.;Mahmoud I Mahmoud.
来源: Chest. 2023年163卷6期e289-e290页

1357. Does Untreated OSA Really Influence Exercise Tolerance?

作者: Tyler A Powell.;Michael J Morris.;Aaron Holley.
来源: Chest. 2023年163卷6期e288-e289页

1358. Response.

作者: Daniel Okin.;Ching-Ying Huang.;George A Alba.;B Taylor Thompson.;Lisa M Bebell.;Peggy S Lai.
来源: Chest. 2023年163卷6期e287-e288页

1359. Response.

作者: Hiroki Tashiro.;Yuki Kuwahara.;Koichiro Takahashi.;Naoko Sueoka-Aragane.
来源: Chest. 2023年163卷6期e286页

1360. Extended Prone Positioning Duration, But After How Many Sessions?

作者: Thaïs Walter.;David Hajage.;Jean-Damien Ricard.
来源: Chest. 2023年163卷6期e286-e287页
共有 38500 条符合本次的查询结果, 用时 9.4237839 秒